CERRITOS, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI”), one of the largest value-based oncology groups in the United States, announced today that effective July 1, it will be the exclusive oncology provider for over 80,000 Medicaid patients associated with SilverSummit Healthplan in Nevada. TOI is known for bringing state-of-the-art cancer care to the communities it serves, and their presence in the Las Vegas market will provide enhanced access to care and hig ...

TORONTO, June 30, 2025 (GLOBE NEWSWIRE) -- Topicus.com Inc. (the “Corporation”) (TSXV: TOI) today announced that its subsidiary, Topicus.com Coöperatief U.A., has successfully obtained a €200 million senior unsecured Schuldschein loan. The Schuldschein loan was initially launched at €100 million and was subsequently doubled on the back of significant interest from institutional lenders. The Schuldschein loan is structured in several tranches at variable rates, with €79.5 million maturing in 3 years, €105.5 m ...

CERRITOS, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI”), one of the largest value-based oncology groups in the United States, today announced that it will join the Russell 2000® and Russell 3000® after the 2025 Russell indexes annual reconstitution, effective after the US market closes on June 27, according to a preliminary list of additions posted on May 23. Annual Russell indexes reconstitution captures the 4,000 largest US stocks as of April 30, ranking them ...

The Oncology Institute (TOI) Q1 2025 Earnings Call May 14, 2025 05:00 PM ET Company Participants Mark Hueppelsheuser - General CounselDaniel Virnich - Chief Executive OfficerRob Carter - Chief Financial OfficerDavid Larsen - Managing DirectorYuan Zhi - Managing DirectorBill Sutherland - Director of Research Conference Call Participants Robert Leboyer - Senior Biotechnology Analyst Operator Good afternoon, and welcome to the Oncology Institute's First Quarter twenty twenty five Earnings Conference Call. Toda ...

The Oncology Institute (TOI) Q1 2025 Earnings Call May 14, 2025 05:00 PM ET Speaker0 Good afternoon, and welcome to the Oncology Institute's First Quarter twenty twenty five Earnings Conference Call. Today's call is being recorded, and we have allocated one hour for prepared remarks and Q and A. At this time, I'd like to turn the conference over to Mark Heplheiser, General Counsel at TOI. Thank you. You may begin. Speaker1 The press release announcing the Oncology Institute's results for the first quarter o ...

Exhibit 99.1 The Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance CERRITOS, Calif., May 14, 2025 -- The Oncology Institute, Inc. (NASDAQ: TOI) ("TOI" or the "Company"), one of the largest value-based community oncology groups in the United States, today reported financial results for its three months ended March 31, 2025. Recent Operational Highlights First Quarter 2025 Financial Highlights • Retail Pharmacy and Dispensary set fill records, contributing $ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission file number 001-39248 The Oncology Institute, Inc. (Exact name of registrant as specified in its charter) Delaware 84-3562323 (State ...

CERRITOS, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its three months ended March 31, 2025. Recent Operational Highlights Retail Pharmacy and Dispensary set fill records, contributing $49.3 million revenue and over $9 million in gross profit in Q1. The Pharmacy and Dispensary segment grew over 20% in the first quarter of 2025 v ...

CERRITOS, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI”), one of the largest value-based oncology groups in the United States, announced today that Dr. Jeffrey Langsam will assume the role of enterprise Chief Clinical Officer effective May 13th, 2025. The CCO role will oversee therapeutics including pathway and procurement decisions, utilization management, and MSO practice clinical engagement. Dr. Langsam joins TOI from Cigna Healthcare, where he was the Nationa ...

公司动态 - 公司于2025年5月13日年度股东大会选举五名董事提名人进入董事会，分别是John Billowits、Alex Macdonald、Lori O'Neill、Donna Parr和Robin van Poelje [1] - Jane Holden未在年度股东大会上竞选连任公司董事会成员，公司感谢其作为董事会成员的贡献 [2] 公司介绍 - 公司是领先的泛欧垂直市场软件和平台提供商，服务于公共和私营部门市场客户，在欧洲有长期增长潜力的国家和市场开展业务和投资，收购、构建和管理领先软件公司，提供满足客户特定需求的专业、关键任务和高影响力软件解决方案 [3] 联系方式 - 首席财务官Jamal Baksh，联系电话416 - 861 - 9677，邮箱info@csisoftware.com [4]